The Cellie Coping Kit for Sickle Cell Disease: Initial Acceptability and Feasibility
Overview
Authors
Affiliations
Sickle Cell Disease (SCD) and its treatment can place physical and psychosocial strain on children and their families, underlining the need for behavioral and emotional support. Much of SCD is often managed at home, which may prevent children from obtaining supportive services from medical and psychosocial teams. Children with SCD report a restricted number of coping strategies specific to managing SCD and may benefit from education on adaptive coping. To address this unmet need, a coping tool for children with cancer (Cellie Cancer Coping Kit) was adapted for children with SCD. The Cellie Coping Kit for SCD (Cellie Coping Kit) includes a stuffed "Cellie" toy, coping cards for children, and a book for caregivers. This study sought to assess the acceptability and feasibility of an intervention utilizing the Cellie Coping Kit. Fifteen children with SCD (ages 6-14) and their caregivers participated in a baseline assessment including semi-structured interviews to examine SCD-related stressors and coping strategies. Next, families received a brief introduction to the Cellie Coping Kit and were provided with a kit to use independently over the next four weeks before completing a follow-up assessment. Results indicated strong intervention acceptability overall. While families reported using and learning information and skills from the Cellie Coping Kit, several challenges were identified (e.g., child's living situation, busy schedules). The Cellie Coping Kit is a promising tool to support children with SCD and their families. Future research should examine whether use of the Cellie Coping Kit impacts behavioral change and improved health outcomes.
Depression and Anxiety Symptoms During and After Pediatric Asthma Hospitalization.
Morin H, Worsley D, Zhang X, Faerber J, Pettit A, Kenyon C Hosp Pediatr. 2021; 11(11):1272-1280.
PMID: 34670757 PMC: 9703356. DOI: 10.1542/hpeds.2020-000950.
Improving self-management in adolescents with sickle cell disease.
Crosby L, Hood A, Kidwell K, Nwankwo C, Peugh J, Strong H Pediatr Blood Cancer. 2020; 67(10):e28492.
PMID: 32697889 PMC: 7722105. DOI: 10.1002/pbc.28492.
Marsac M, Sprang G, Guller L, Kohser K, Draus Jr J, Kassam-Adams N Trials. 2019; 20(1):137.
PMID: 30777113 PMC: 6380044. DOI: 10.1186/s13063-019-3207-9.